Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Horizon Pharma

Horizon Pharma reported $2.31B in Cash and Equivalent for its fiscal quarter ending in March of 2023.

Cash And Equivalent Change
Amgen AMGN:US USD 31.56B 22.26B
AstraZeneca AZN:LN USD 6.23B 66M
Bausch Health Companies Inc VRX:CN USD 518M 46M
Bristol-Myers Squibb BMY:US USD 9B 128M
Cara Therapeutics CARA:US USD 47.39M 16.35M
Coherus Biosciences CHRS:US USD 16.14M 47.4M
Eli Lilly LLY:US USD 3.55B 1.48B
Endo International ENDP:US USD 903.61M 115.27M
Horizon Pharma HZNP:US USD 2.31B 41.2M
Novartis NOVN:VX USD 12B 4.48B
Pacira PCRX:US USD 35.54M 68.59M
Perrigo PRGO:US USD 553M 47.7M
Prestige Brands PBH:US USD 58.49M 27.87M
Revance Therapeutics RVNC:US USD 136.68M 27.71M
Supernus Pharmaceuticals SUPN:US USD 58.44M 34.68M
Takeda 4502:JP JPY 533.53B 151.61B
Xeris Pharmaceuticals Inc XERS:US USD 50.98M 70.98M
Zoetis ZTS:US USD 2.1B 1.47B